CytoMed Therapeutics
GDTC
#9803
Rank
โ‚น2.27 B
Marketcap
โ‚น197.34
Share price
-7.08%
Change (1 day)
10.21%
Change (1 year)

EPS for CytoMed Therapeutics (GDTC)

EPS in 2021: -โ‚น11.83

According to CytoMed Therapeutics's latest financial reports the company's current EPS (TTM) is -โ‚น11.83. In 2021 the company made an earnings per share (EPS) of -โ‚น11.83 a decrease over its 2020 EPS that were of -โ‚น11.41.

EPS history for CytoMed Therapeutics from 2020 to 2021

Annual EPS

Year EPS Change
2021-โ‚น11.833.73%
2020-โ‚น11.41